Acute cholangitis in intensive care units: clinical, biological, microbiological spectrum and risk factors for mortality: a multicenter study.
Cholangitis
Intensive care unit
Microbiology
Outcome
Prognosis
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
06 02 2021
06 02 2021
Historique:
received:
13
11
2020
accepted:
25
01
2021
entrez:
7
2
2021
pubmed:
8
2
2021
medline:
26
8
2021
Statut:
epublish
Résumé
Little is known on the outcome and risk factors for mortality of patients admitted in Intensive Care units (ICUs) for Acute cholangitis (AC). Retrospective multicenter study included adults admitted in eleven intensive care units for a proven AC from 2005 to 2018. Risk factors for in-hospital mortality were identified using multivariate analysis. Overall, 382 patients were included, in-hospital mortality was 29%. SOFA score at admission was 8 [5-11]. Biliary obstruction was mainly related to gallstone (53%) and cancer (22%). Median total bilirubin and PCT were respectively 83 µmol/L [50-147] and 19.1 µg/L [5.3-54.8]. Sixty-three percent of patients (n = 252) had positive blood culture, mainly Gram-negative bacilli (86%) and 14% produced extended spectrum beta lactamase bacteria. At ICU admission, persisting obstruction was frequent (79%) and biliary decompression was performed using therapeutic endoscopic retrograde cholangiopancreatography (76%) and percutaneous transhepatic biliary drainage (21%). Adjusted mortality significantly decreased overtime, adjusted OR for mortality per year was 0.72 [0.54-0.96] (p = 0.02). In a multivariate analysis, factors at admission associated with in-hospital mortality were: SOFA score (OR 1.14 [95% CI 1.05-1.24] by point, p = 0.001), lactate (OR 1.21 [95% CI 1.08-1.36], by 1 mmol/L, p < 0.001), total serum bilirubin (OR 1.26 [95% CI 1.12-1.41], by 50 μmol/L, p < 0.001), obstruction non-related to gallstones (p < 0.05) and AC complications (OR 2.74 [95% CI 1.45-5.17], p = 0.002). Time between ICU admission and biliary decompression > 48 h was associated with in-hospital mortality (adjusted OR 2.73 [95% CI 1.30-6.22], p = 0.02). In this large retrospective multicenter study, we found that AC-associated mortality significantly decreased overtime. Severity of organ failure, cause of obstruction and local complications of AC are risk factors for mortality, as well as delayed biliary drainage > 48 h.
Sections du résumé
BACKGROUND
Little is known on the outcome and risk factors for mortality of patients admitted in Intensive Care units (ICUs) for Acute cholangitis (AC).
METHODS
Retrospective multicenter study included adults admitted in eleven intensive care units for a proven AC from 2005 to 2018. Risk factors for in-hospital mortality were identified using multivariate analysis.
RESULTS
Overall, 382 patients were included, in-hospital mortality was 29%. SOFA score at admission was 8 [5-11]. Biliary obstruction was mainly related to gallstone (53%) and cancer (22%). Median total bilirubin and PCT were respectively 83 µmol/L [50-147] and 19.1 µg/L [5.3-54.8]. Sixty-three percent of patients (n = 252) had positive blood culture, mainly Gram-negative bacilli (86%) and 14% produced extended spectrum beta lactamase bacteria. At ICU admission, persisting obstruction was frequent (79%) and biliary decompression was performed using therapeutic endoscopic retrograde cholangiopancreatography (76%) and percutaneous transhepatic biliary drainage (21%). Adjusted mortality significantly decreased overtime, adjusted OR for mortality per year was 0.72 [0.54-0.96] (p = 0.02). In a multivariate analysis, factors at admission associated with in-hospital mortality were: SOFA score (OR 1.14 [95% CI 1.05-1.24] by point, p = 0.001), lactate (OR 1.21 [95% CI 1.08-1.36], by 1 mmol/L, p < 0.001), total serum bilirubin (OR 1.26 [95% CI 1.12-1.41], by 50 μmol/L, p < 0.001), obstruction non-related to gallstones (p < 0.05) and AC complications (OR 2.74 [95% CI 1.45-5.17], p = 0.002). Time between ICU admission and biliary decompression > 48 h was associated with in-hospital mortality (adjusted OR 2.73 [95% CI 1.30-6.22], p = 0.02).
CONCLUSIONS
In this large retrospective multicenter study, we found that AC-associated mortality significantly decreased overtime. Severity of organ failure, cause of obstruction and local complications of AC are risk factors for mortality, as well as delayed biliary drainage > 48 h.
Identifiants
pubmed: 33549136
doi: 10.1186/s13054-021-03480-1
pii: 10.1186/s13054-021-03480-1
pmc: PMC7866656
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
49Références
Clin Gastroenterol Hepatol. 2012 Oct;10(10):1157-61
pubmed: 22507875
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):17-30
pubmed: 29032610
Clin Microbiol Infect. 2013 Feb;19(2):141-60
pubmed: 22117544
N Engl J Med. 1992 Jun 11;326(24):1582-6
pubmed: 1584258
Gastrointest Endosc. 2013 Jul;78(1):81-90
pubmed: 23528654
Aliment Pharmacol Ther. 2015 Jul;42(2):212-20
pubmed: 25997554
Gastrointest Endosc. 2018 Jan;87(1):185-192
pubmed: 28433613
Crit Care. 2019 Sep 6;23(1):306
pubmed: 31492179
Eur Respir J. 2016 Sep;48(3):797-807
pubmed: 27174880
J Hepatobiliary Pancreat Sci. 2017 Jun;24(6):329-337
pubmed: 28419764
Aliment Pharmacol Ther. 2016 Oct;44(7):755-66
pubmed: 27506331
J Hepatobiliary Pancreat Sci. 2017 Jun;24(6):310-318
pubmed: 28371094
J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):31-40
pubmed: 28941329
Am J Respir Crit Care Med. 2014 May 15;189(10):1204-13
pubmed: 24635548
Intensive Care Med. 2016 Dec;42(12):1980-1989
pubmed: 27686355
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Dig Dis Sci. 2013 Jul;58(7):2082-7
pubmed: 23456495
Chest. 2002 Jul;122(1):262-8
pubmed: 12114368
Am J Respir Crit Care Med. 2003 Jul 15;168(2):165-72
pubmed: 12851245
Clin Infect Dis. 2010 Jan 15;50(2):133-64
pubmed: 20034345
Crit Care. 2018 Apr 16;22(1):93
pubmed: 29656714
QJM. 2005 Apr;98(4):291-8
pubmed: 15760921
Crit Care. 2019 Sep 6;23(1):307
pubmed: 31492201
Prz Gastroenterol. 2018;13(1):16-21
pubmed: 29657606
Am J Gastroenterol. 2007 Mar;102(3):563-9
pubmed: 17335448